Mobile van + peer help aims to boost HIV prevention in black MSM

NCT ID NCT07133555

First seen Jun 25, 2026 · Last updated Jun 25, 2026

Summary

This study expands on a previous mobile van HIV/STI testing program for men who have sex with men (MSM) in online spaces. Researchers will add a peer health navigator to help participants get PrEP or HIV care after testing. The study will compare this navigator approach to a referrals-only approach in 100 Black MSM aged 18-49 in Baltimore.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Johns Hopkins School of Medicine

    NOT_YET_RECRUITING

    Baltimore, Maryland, 21287, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

peer health navigator counseling

What this could lead to

If successful, this approach could improve HIV prevention and care access for Black men who have sex with men in online spaces.

What could go wrong

This is a small, early feasibility study (100 participants) focused on process outcomes, not a large-scale efficacy trial. Results may not generalize to other populations or settings.

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.